Home

Nutriție Interpret a inflori timp as a prognostic marker in colorectal eșarfă De neînlocuit A tăia

Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer | BMC Cancer  | Full Text
Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer | BMC Cancer | Full Text

Do Young Patients with Colorectal Cancer Have a Poorer Prognosis than Old  Patients? - Journal of Surgical Research
Do Young Patients with Colorectal Cancer Have a Poorer Prognosis than Old Patients? - Journal of Surgical Research

Frontiers | The Versatile Roles of Cancer-Associated Fibroblasts in  Colorectal Cancer and Therapeutic Implications
Frontiers | The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications

TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A  meta-analysis | PLOS ONE
TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis | PLOS ONE

Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for  the Clinical Surgeon | SpringerLink
Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon | SpringerLink

Extravesicular TIMP-1 is a non-invasive independent prognostic marker and  potential therapeutic target in colorectal liver metastases | Oncogene
Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases | Oncogene

(PDF) Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
(PDF) Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer

Prognostic impact of the expression of putative cancer stem cell markers  CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer | British  Journal of Cancer
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer | British Journal of Cancer

DDX39B drives colorectal cancer progression by promoting the stability and  nuclear translocation of PKM2 | Signal Transduction and Targeted Therapy
DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2 | Signal Transduction and Targeted Therapy

Extravesicular TIMP-1 is a non-invasive independent prognostic marker and  potential therapeutic target in colorectal liver metastases | Oncogene
Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases | Oncogene

Serum Cellular Apoptosis Susceptibility Protein Is a Potential Prognostic  Marker for Metastatic Colorectal Cancer - The American Journal of Pathology
Serum Cellular Apoptosis Susceptibility Protein Is a Potential Prognostic Marker for Metastatic Colorectal Cancer - The American Journal of Pathology

The expression of TIMP-1 and TIMP-2 in tumortissues and adjacent normal...  | Download Scientific Diagram
The expression of TIMP-1 and TIMP-2 in tumortissues and adjacent normal... | Download Scientific Diagram

Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker  in gastrointestinal cancer: a meta-analysis [PeerJ]
Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis [PeerJ]

Overall survival of 250 rectal cancer patients divided into three... |  Download Scientific Diagram
Overall survival of 250 rectal cancer patients divided into three... | Download Scientific Diagram

Disease-specific survival in colorectal cancer patients according to... |  Download Scientific Diagram
Disease-specific survival in colorectal cancer patients according to... | Download Scientific Diagram

Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in  Colon Cancer
Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in Colon Cancer

Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic  Options
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options

Profiling Markers of Prognosis in Colorectal Cancer
Profiling Markers of Prognosis in Colorectal Cancer

IJMS | Free Full-Text | Extracellular Matrix Biomarkers in Colorectal  Cancer | HTML
IJMS | Free Full-Text | Extracellular Matrix Biomarkers in Colorectal Cancer | HTML

Prognostic Impact of Tissue Inhibitor of Matrix Metalloproteinase- 1 in  Plasma of Patients with Colorectal Cancer
Prognostic Impact of Tissue Inhibitor of Matrix Metalloproteinase- 1 in Plasma of Patients with Colorectal Cancer

TIMP-1 as a Prognostic Marker in Colorectal Cancer | SpringerLink
TIMP-1 as a Prognostic Marker in Colorectal Cancer | SpringerLink

Preoperative plasma TIMP-1 is an independent prognostic indicator in  patients with primary colorectal cancer: A prospective validation study -  European Journal of Cancer
Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: A prospective validation study - European Journal of Cancer

Current advances in prognostic and diagnostic biomarkers for solid cancers:  Detection techniques and future challenges - ScienceDirect
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect

Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal  Cancer: A Prospective Validation Study Including Symptomati
Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomati

Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or  proteins?
Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?

TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A  meta-analysis | PLOS ONE
TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis | PLOS ONE

PDF) Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1  correlate with clinical markers of cachexia in patients with chronic  pancreatitis and pancreatic cancer
PDF) Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer